H22-Luc-hGPC3

PDFを取得

Strain Information

表現型データ

1. In vitro Expression of H22-Luc-hGPC3 cell line

hGPC3 expression was measured in H22-Luc-hGPC3 cell by FACS . FACS results showed that significant hGPC3 expression on the H22-Luc-hGPC3 cell line.

image.png

Figure 1 hGPC3 expression in H22-Luc-hGPC3 cell line

2. Characterization of in vivo growth kinetics


To verify tumor formation of H22-Luc-hGPC3 cell line, cells were subcutaneously inoculated into female balb/c mice.

image.png

Figure 2. Tumor growth curve of H22-Luc-hGPC3 allogeneic model (n=5)

image.pngimage.png

Figure 3. Body weight curve of H22-Luc-hGPC3 allogeneic model (n=5)

3. Expression of hGPC3 in tumors

To verify the hGPC3 protein expression, the tumors were dissected and separated for single cell suspension when he tumor volume is 500-1000mm3. Robust hGPC3 protein expression can be detected in the humanized modified tumors.

image.png

Figure 4. The expression of hGPC3 in humanized modified tumors by FACS



関連の系統

あなたも好きかも

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

詳細
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

詳細